The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of Rs1139971, a KAI1 polymorphism, with bone metastasis progression in prostate cancer and ganglionnary metastasis.
Marie Audouin
No relevant relationships to disclose
Géraldine Cancel Tassin
No relevant relationships to disclose
Cécile Gaffory
No relevant relationships to disclose
Valérie Ondet
No relevant relationships to disclose
Stephane Oudard
No relevant relationships to disclose
Abdel Rahmene Azzouzi
No relevant relationships to disclose
Morgan Roupret
No relevant relationships to disclose
Olivier Cussenot
No relevant relationships to disclose